Malignancy Meta Analysis for BRL49653

NCT01195259 · clinicaltrials.gov ↗

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: allocation of treatment with metformin or rosiglitazone

Sponsor

GlaxoSmithKline